Actual Medicinal Product (AMP) Medrone 4mg tablets (Pfizer Ltd)

Stability Information

(Some stability information inherited from generic)

Stability
compatible_special_measures logo Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
Notes

Protect from light Anecdotal reports of use in MCAs (low quality evidence)

Provenance

This recommendation is based on the product Medrone 4mg tablets (Pfizer Limited).

Generic
Methylprednisolone
Formulation
Methylprednisolone 4mg tablets
  • Methylprednisolone
    • Methylprednisolone 4mg tablets

      • Medrone 4mg tablets (Pfizer Ltd)

Alternative Suppliers (1)

compatible_special_measures logo Medrone 4mg tablets (Pfizer Ltd)